Chad Bigelow

Chad Bigelow

Company: Novartis Institutes for BioMedical Research

Job title: Associate Director, Ophthalmology Research


Chad Bigelow, PhD is an associate director in ophthalmology research at the Novartis Institutes for BioMedical Research (NIBR). He is currently the head of the ocular imaging lab, where his focus is developing translatable biomarkers for use in animal model development and drug discovery.  Currently the group is using a combination of imaging, behavioral assays, and visual electrophysiology for quantifying structural and functional changes associated with disease pathology. Prior to joining Novartis, he worked on developing new techniques for revealing microscopic changes in the eye through the application of adaptive optics techniques to optical coherence tomography and scanning laser ophthalmoscopy imaging. He received his undergraduate degree in engineering physics from the University of Michigan and PhD in Optics from the Institute of Optics at the University of Rochester.


Development of Preclinical Models Supporting CPK850 for RLBP1 Retinitis Pigmentosa 2:00 pm

• Understanding the limitations of preclinical animal models is key to developing a path to the clinic for gene therapies • Probing multiple species informs the nonclinical safety profile • A combination of biologically-relevant animal models and translatable biomarkers increases confidence in efficacy-based dose selectionRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.